VTGN

Conviction 36HealthcareScan · Fri, Jun 26, 2026

VTGN$0.7094+15.05%

ResistanceSupportVol 14

Vol MA14 1.24M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Vistagen Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.vistagen.com ↗

Price0.7094

Change+15.05%

Gap+8.63%

Rel volume1.90×

Avg volume1.08M

Avg $ vol690.49K

SMA 200.6091

SMA 500.6139

SMA 2001.77

Price vs 50+15.55%

Price vs 200-59.97%

MA stackmixed

50/200 cross—

Supertrendup · 0.5204

RSI (14)61

MACD hist0.01

MACD crossbull · 7d

Stoch %K / %D89 / 68

ADX (14)18

+DI / −DI22 / 13

RSI divergence—

MACD divergence—

ATR %+9.35%

ADR %10.15%

52w high4.90

52w low0.5050

From 52w high-85.52%

Above 52w low+40.48%

New 52w highNo

SqueezeOff

Bollinger width36.41%

%B0.95

Donchian pos88.84%

Donchian high0.7332

Donchian low0.5200

AVWAP (52w high)0.9443

vs AVWAP high-24.88%

AVWAP (52w low)0.6054

vs AVWAP low+17.18%

OBV trendFlat

Chaikin MF (20)0.00

Today vs 20d1.90×

Avg vol (14d)1.24M

Avg vol (20d)1.08M

Avg $ vol (20d)690.49K

Market cap—

RS 3m (vs SPY)-10.76%

RS 6m (vs SPY)-24.79%

RS line new highNo

Trend template2/8

Technical rank46.4

1 week+5.85%

1 month+13.67%

3 months+17.29%

6 months-0.52%

1 year-65.05%

YTD+4.48%

P/E-0.35

P/B0.69

P/S-108.40

P/FCF-0.37

EPS-1.83

Div yield—

ROE-196.19%

ROA-143.49%

Debt/Eq-0.04

Current3.67

EV/EBITDA0.11

Gross margin—

Net margin—

Rev growth-120.47%

EPS growth-35.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-7.69M

Revenue354.1K

Net income-18.9M

Gross profit—

Free cash flow-66.64M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out39.62M

Employees59

ListedWed, Jul 1, 2009

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction36 / 100

Pattern quality—

Tech rank46.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7135

Support0.5273

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in VTGN

All disclosures →

No recent disclosed trades by Congress in VTGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VTGN · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Angelov Angel S Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-18	Grant	150K	—	2026-05-18	2026-05-19
Singh Shawn President and CEO · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	71.27K	$0	2026-04-07	2026-04-09
Adler Reid G. Chief Legal Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	18.75K	$0	2026-04-07	2026-04-09
Tressler Nick B. Chief Financial Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	75K	$0	2026-04-07	2026-04-09
Cote Elissa S. Chief Corp Development Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	75K	$0	2026-04-07	2026-04-09
Singh Shawn President and CEO · Incentive Stock Option (right to buy) · 2026-04-07	Grant	3.73K	$0	2026-04-07	2026-04-09
Adler Reid G. Chief Legal Officer · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	56.25K	$0	2026-04-07	2026-04-09
Prince Joshua S. Chief Operating Officer · Non-Qualified Stock Option (right to buy) · 2026-04-07	Grant	56.25K	$0	2026-04-07	2026-04-09
Prince Joshua S. Chief Operating Officer · Incentive Stock Option (right to buy) · 2026-04-07	Grant	18.75K	$0	2026-04-07	2026-04-09

SEC filings

EDGAR filings in VTGN · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.